Charles Schwab’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$224K Hold
2017
Q3
$248K Hold
2017
Q2
$225K Buy
2016
Q4
Sell
2016
Q3
$43K Hold
2016
Q2
$25K Sell
2016
Q1
$226K Hold
2015
Q4
$394K Hold
2015
Q3
$487K Hold
2015
Q2
$664K Buy
2015
Q1
$212K Hold
2014
Q4
$247K Hold
2014
Q3
$249K Hold
2014
Q2
$420K Buy
2014
Q1
$77K Hold
2013
Q4
$46K Hold
2013
Q3
$53K Hold
2013
Q2
$42K Buy